Abstract
Prodigiosin (PG) is chemically formulated as 4-methoxy-5-[(5-methyl-4-pentyl-2H-pyrrol-2ylidene)methyl]-2,2′-bi-1H-pyrrole and it is an apoptotic agent. Only a few protein targets for PG have been identified so far for regulating various diseases; nevertheless, finding more PG targets is crucial for novel drug discovery research. A bioinformatics method was applied in this work to find additional potential PG targets. Initially, a text mining analysis was conducted to determine the relationship between PG and a variety of metabolic processes. One hundred sixteen proteins from the KEGG pathway were selected for the docking study. Inverse virtual screening was performed by Discovery Studio software 4.1 using CHARMm-based docking tool. Twelve proteins are screened out of 116 because their CDOCKER interaction energy is larger than − 40.22 kcal/mol. The best docking score with PG was reported to be − 44.25 kcal/mol, − 44.99 kcal/mol, and − 40.91 kcal/mol for three novel proteins, such as human epidermal growth factor-2 (HER-2), mitogen-activated protein kinase (MEK), and S6 kinase protein (S6K) respectively. The interactions in the S6K/PG complex are predominantly hydrophobic; however, hydrogen bond interactions can be identified in the MEK/PG and HER-2/PG complexes. The root-mean-square deviation (RMSD) and key interaction score system (KISS) were further used to validate the docking approach. The docking approach employed in this work has a low RMSD value (2.44 Å) and a high KISS score (0.5), indicating that it is significant.
Similar content being viewed by others
Data Availability
The data generated or obtained during this research's experiment is available to the associated author (Tania Paul), and can be made available to this journal at a fair cost upon request.
References
Sharma, R., Bhunia, B., Mondal, A., Bandyopadhyay, T. K., Devi, I., Oinam, G., Prasanna, R., Abraham, G., & Tiwari, O. N. (2020). Ultrasonics sonochemistry., 60, 104762.
Nath, P. C., Bandyopadhyay, T. K., Mahata, N., Pabbi, S., Tiwari, O. N., Indira, M., & Bhunia, B. (2022). Biomass Conversion and Biorefinery., 1, 1–12.
Paul, T., Bandyopadhyay, T. K., Mondal, A., Tiwari, O. N., Muthuraj, M., & Bhunia, B. (2020). Biomass Conversion and Biorefinery., 20, 1–23.
Paul, T., Bandyopadhyay, T. K., Mondal, A., & Bhunia, B. (2020). Journal of the Indian Chemical Society, 97, 434–439.
Paul, T., Mondal, A., Bandyopadhyay, T. K., & Bhunia, B. (2022). Biomass Conversion and Biorefinery, 1, 1–20.
Ibrahim, D., Nazari, T. F., Kassim, J., & Lim, S.-H. (2014). Journal Applied Pharmacology Science, 4, 1–6.
Papireddy, K., Smilkstein, M., & Kelly, J. (2011). Journal of Medicinal Chemistry, 54, 5296–5306.
Do, H. N., & Nguyen, T. H. (2014). Journal of Applied Pharmaceutical. Science, 4, 21.
Kim, D. K., Park, Y. K., Lee, J. S., Kim, F. J. H., Jeong, H. Y., Kim, B. S., & Lee, C. H. (2006). Online Journal of Biological Sciences. Journal of microbiology and biotechnology., 16, 1912–1918.
Khanafari, A., Assadi, M. M., & Fakhr, F. A. (2006). Online Journal of Biological Sciences., 6, 1–13.
Kawasaki, T., Sakurai, F., & Hayakawa, Y. (2008). Journal of natural products., 71, 1265–1267.
Darshan, N., & Manonmani, H. (2016). AMB Express, 6, 1–12.
Siva, R., Subha, K., Bhakta, D., Ghosh, A., & Babu, S. (2012). Applied Biochemistry and Biotechnology., 166, 187–196.
Elahian, F., Moghimi, B., Dinmohammadi, F., Ghamghami, M., Hamidi, M., & Mirzaei, S. A. (2013). DNA and Cell Biology., 32, 90–97.
Kavitha, R., Aiswariya, S., & Ratnavali, C. M. J. (2010). International Journal of PharmTech Research, 2, 784–787.
Paul, T., Mondal, A., Bandyopadhyay, T. K., Mahata, N., & Bhunia, B. (2022). Applied Biochemistry and Biotechnology, 1, 1–16.
Pérez-Tomás, R., Montaner, B., Llagostera, E., & Soto-Cerrato, V. (2003). Biochemical Pharmacology, 66, 1447–1452.
Williamson, N. R., Fineran, P. C., Leeper, F. J., & Salmond, G. P. (2006). Nature Reviews Microbiology, 4, 887–899.
Regourd, J., Al-Sheikh Ali, A., & Thompson, A. J. (2007). Journal of Medicinal Chemistry, 50, 1528–1536.
Hong, B., Prabhu, V. V., Zhang, S., van den Heuvel, A. P. J., Dicker, D. T., Kopelovich, L., & El-Deiry, W. S. (2014). Cancer Research, 74, 1153–1165.
Montaner, B., Navarro, S., Piqué, M., Vilaseca, M., Martinell, M., Giralt, E., Gil, J., & Pérez‐Tomás, R. (2000). British Journal of Pharmacology, 131, 585–593.
Bhardwaj, P., Biswas, G., Mahata, N., Ghanta, S., & Bhunia, B. (2022). Chemosphere, 293, 133550.
Wu, G., Robertson, D. H., Brooks, C. L., III., & Vieth, M. (2003). Journal of computational chemistry., 24, 1549–1562.
Sulimov, A. V., Kutov, D. C., Katkova, E. V., Ilin, I. S., & Sulimov, V. B. (2017). Journal of Molecular Graphics and Modelling., 78, 139–147.
Gagnon, J. K., Law, S. M., & Brooks, C. L., III. (2016). Journal of computational chemistry., 37, 753–762.
Venkatachalam, C. M., Jiang, X., Oldfield, T., & Waldman, M. (2003). Journal of Molecular Graphics and Modelling., 21, 289–307.
Naresh, R., Nazeer, Y., & Palani, S. (2013). Medicinal Chemistry Research., 22, 1938–1947.
Bhardwaj, P., Biswas, G., & Bhunia, B. (2019). Chemosphere, 235, 976–984.
Ostacolo, C., Di Sarno, V., Lauro, G., Pepe, G., Musella, S., Ciaglia, T., Vestuto, V., Autore, G., Bifulco, G., & Marzocco, S. (2019). European journal of medicinal chemistry., 167, 61–75.
Krishna, P. S., Vani, K., Prasad, M. R., Samatha, B., Surya, N. S. V. S. S., Bindu, L. H., Charya, M. A. S., & Shetty, P. R. (2013). Springerplus., 2, 1–6.
D’Mello, P., Gadhwal, M. K., Joshi, U., & Shetgiri, P. (2011). International Journal of Pharmacy and Pharmaceutical Sciences, 3, 33–40.
Hsieh, H. Y., Shieh, J. J., Chen, C. J., Pan, M. Y., Yang, S. Y., Lin, S. C., Chang, J. S., Lee, A. Y. L., & Chang, C. C. (2012). British journal of pharmacology., 166, 2095–2108.
Hong, B., Prabhu, V. V., Zhang, S., van den Heuvel, A. P. J., Dicker, D. T., Kopelovich, L., & El-Deiry, W. S. (2014). Cancer research., 74, 1153–1165.
Anwar, M. M., Shalaby, M., Embaby, A. M., Saeed, H., Agwa, M. M., & Hussein, A. (2020). Scientific Reports., 10, 1–15.
Montaner, B., Navarro, S., Piqué, M., Vilaseca, M., Martinell, M., Giralt, E., Gil, J., & Pérez-Tomás, R. (2000). British journal of pharmacology., 131, 585–593.
Darshan, N., & Manonmani, H. (2015). Journal of food science and technology., 52, 5393–5407.
Lu, C.-H., Lin, S.-C., Yang, S.-Y., Pan, M.-Y., Lin, Y.-W., Hsu, C.-Y., Wei, Y.-H., Chang, J.-S., & Chang, C.-C. (2012). Toxicology Letters, 212, 83–89.
Zhao, K., Li, D., Cheng, G., Zhang, B., Han, J., Chen, J., Wang, B., Li, M., Xiao, T., Zhang, J., Zhou, D., Jin, Z., & Fan, X. (2019). International Journal of Molecular Sciences, 20, 5458.
Meng, X.-Y., Zhang, H.-X., Mezei, M., & Cui, M. (2011). Current computer-aided drug design., 7, 146–157.
Gutierrez, C., & Schiff, R. (2011). Archives of pathology & laboratory medicine., 135, 55–62.
McCubrey, J. A., Steelman, L. S., Chappell, W. H., Abrams, S. L., Wong, E. W., Chang, F., Lehmann, B., Terrian, D. M., Milella, M., & Tafuri, A. (2007). Biochimica et Biophysica Acta (BBA)-Molecular Cell Research, 1773, 1263–1284.
Holz, M. K. (2012). Cell Cycle, 11, 3159–3165.
Udatha, D. G., Sugaya, N., Olsson, L., & Panagiotou, G. (2012). Scientific reports., 2, 323.
Hevener, K. E., Zhao, W., Ball, D. M., Babaoglu, K., Qi, J., White, S. W., & Lee, R. E. (2009). Journal of chemical information and modeling., 49, 444–460.
Udatha, D. G., Sugaya, N., Olsson, L., & Panagiotou, G. (2012). Scientific reports., 2, 1–8.
Wang, S.-L., Nguyen, V. B., Doan, C. T., Tran, T. N., Nguyen, M. T., & Nguyen, A. D. (2020). Molecules, 25, 2744.
Acknowledgements
Miss. Tania Paul, Mr. Prashant Bhardwaj, Dr. Tarun Kanti Bandyopadhyay, and Dr. Biswanath Bhunia would like to express their heartfelt gratitude to the Director of NIT Agartala for his constant support and encouragement.
Funding
This material is based upon the work supported by the National Institute of Technology, Agartala, India. Dr. Bhunia would like to acknowledge DST, Govt. of India, for Fast Track Young Scientist financial support (SERC/LS-167/2012). Tania Paul would like to express their gratitude to the Department of Bio Engineering, NIT Agartala, for financial support.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation and data collection were performed by Tania Paul and Prashant Bhardwaj, and analysis was performed by Biswanath Bhunia and Tarun Kanti Bandyopadhyay. The first draft of the manuscript was written by Abhijit Mondal and Nibedita Mahata and all authors commented on the previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics Approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Consent to Participate
Informed consent was obtained from all individual participants included in the study.
Consent for Publication
The authors affirm that human research participants provided informed consent for publication of all data provided in the manuscript.
Competing Interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Paul, T., Bhardwaj, P., Mondal, A. et al. Identification of Novel Protein Targets of Prodigiosin for Breast Cancer Using Inverse Virtual Screening Methods. Appl Biochem Biotechnol 195, 7236–7254 (2023). https://doi.org/10.1007/s12010-023-04426-9
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12010-023-04426-9